Article info

Download PDFPDF

Extended report
Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION study

Authors

  1. Correspondence to Professor G Jones, Menzies Research Institute, University of Tasmania, Hobart, TAS 7001, Australia; g.jones{at}utas.edu.au
View Full Text

Citation

Jones G, Sebba A, Gu J, et al
Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION study

Publication history

  • Accepted February 19, 2009
  • First published March 17, 2009.
Online issue publication 
November 02, 2019

Article Versions